EMCrit FOAM Feed

EMCrit FOAM Feed

By Scott D. Weingart, MD FCCMScienceMedicineHealth & Fitness
Download on the App Store
  • Favorites

    1,064

    Followers

  • Latest release

    7 days ago

  • Typical duration

    29 min

    per episode

  • If it hooks

    52%

    finish an episode

Based on Podcast App listening data

All EMCrit FOAM Feed episodes

  • EMCrit 266 – High Sensitivity Troponins with Louise Cullen
    Today on the podcast we discuss High Sensitivity Troponins with Dr. Louise Cullen...
    Professor Louise Cullen
    Louise Cullen is a Senior Staff Specialist in the Department of Emergency Medicine, Royal Brisbane and Women’s Hospital, and an active clinician-researcher with particular interests in acute cardiac diseases, syncope, and cardiac biomarkers. She is widely published in numerous peer-reviewed journal including the Lancet. Her mantra is that “You do not do research for research sake” and as such, clinical redesign and translational research is a key part of her endeavours.
     COI
    Dr. Cullen reports receiving grants from Roche; grants, consultancy fees, and personal fees from Abbott Diagnostics; personal fees from AstraZeneca; and personal fees from Novartis outside of the submitted work.

    We have resolved these conflicts by:

    1. Not speaking of any individual manufacturer's assays

    2. In the US, the manufacturers are eliminating prior assays, thereby obviating the conflict of discussing hsTN (i.e. there will be no purchasing decision on your part--you're getting 'em whether you like it or not)
    High Sensitivity Troponins
    IFCC has released a lab spec sheet on troponins

    Troponin values must be individualized based on your hospital's assay
    ACS Decision Aides

    * IMPACT Trial
    * Comparison of four decision aids for the early diagnosis of acute coronary syndromes in the emergency department
    * MDCalc TMACs
    * MDCALC EDAC
    * HsTNi with decision rules

    Other FOAM

    * EM Topics
    * Hennepin High-Sens Troponin Algorithm

    Now on to the Podcast...
     
    27 min
  • EMCrit 265 – ECPR 2.0 (ECMO CPR)
    [featimage]

    This ECPR interview was origianlly published on edecmo.org. The interview was conducted by my buddy, Zack Shinar. I wanted to expose a broader audience to the episode, so I am reposting it here:
    ECPR 2.0
    The Patient
    1. OOH Cardiac Arrest Patients are Different

    Cannulation
    2. Ultrasound-Guided Percutaneous Placement
    3. Wire choices
    4. Wire Location Verification
    5. Small arterial cannulae
    6. Simpler Circuits

    Post-Pump Critical Care
    7. Find the Injuries
    8. Mandatory leg perfusion
    9. Lower Anticoagulation Goals
    10. Lower Flow Goals
    11. Try to avoid venting – Truby et al. PMID:28422817, less is more
    12. Understanding Cardiac Prognostication / Stunning
    13. Understanding Neuro Prognostication
    14. Protection/Ownership
    15. In it for the Long Haul
    16. Lower Anticoagulation and Hb targets
    17. Parade your Successes to every person in the chain
    Now on to the Podcast...
    39 min
  • EMCrit 264 – Case Discussion of Combined CCB and BB Overdose
    [featimage]

    Today, we discuss a case of a patient who 45 mintues prior to arrival took took 150 Labetalol 100mg and 70 Amlodipine 10mg.
    Prior EMCrit Podcast

    * EMCrit Podcast - Calcium Channel Blocker Overdose

    Hemodynamically Neutral Intubation

    * See this EMCrit Podcast

    3 Presentations for CCB or BB OD

    * Vasodilatory
    * Negative-Inotropy (& Chronotropy)
    * Combined Picture

    Vasopressor-Only Management
    For me this is only appropriate for primarily vasodilatory shock (PMID 23642908, Skoog et al., Levine et al.)
    Tum-E-Vac Commercial Device for Gastric Lavage
    If you believe in lavage...

    from manufacturer site
    Prior Post on Calcium Channel Blocker OD

    * EMCrit Podcast 27

    Extrip on CCB
    Both dialyzability and clinical data do not support a clinical benefit from ECTRs for CCB poisoning. The EXTRIP workgroup recommends against using extracorporeal methods to enhance the elimination of amlodipine, diltiazem, and verapamil in patients with severe poisoning. [10.1080/15563650.2020.1870123]
    Tox & Hound on Mechanism of Insulin

    * Insulin for CCB/BB OD

    Now on to the Podcast...
    35 min
  • EMCrit Podcast 263 – The Venous Side – Part 1 – VEXUS Score with Phillipe Rola
    [featimage]

    Today, we discuss the VEXUS Score. One of the big philosophical mistakes of early EMCrit was my approach to fluids in sepsis. It is no excuse that I was in good company--as in most of the intensivists in the US. I've come to my senses in the past 8 years or so and now I am actively fighting to avoid the drowning of our patients. One of the stalwarts in that fight is my buddy Phillipe Rola. He is an intensivist in Montreal, EMCrit team member, and creator of the Thinking Critical Care Blog.

    He, along with Rory Spiegel and Korbin Haycock, has created the VEXUS score to evaluate your patient for fluid overload.
    VEXUS Article
    VEXUS Article
    VEXUS Score

    Hepatic Vein
    Look at the IVC in the sub-xiphoid

    Phased Array Probe may be easiest, but Curvilinear works as well

    S wave should be larger than D wave

    TR may be a confounder

    S just after QRS if you have ECG leads
    Portal Vein
    Mid-Ax Line on Right Side with probe longitiduinal or R Costal Margin

    Use curvilinear

    Flow should move towards probe (red)

    Normal is continuous flow

    If it becomes pulsatile, there is backpressure

    If it drops below baseline that is bad

    PF <=0.5 (same thing as resistive index)

    may be abnormal in pts with low BMI
    Renal Artery
    Curvilinear with Abd preset

    Use color doppler to find vessels

    Pick a vessel and look at the PW wave

    RRI

    0.55-0.7 is normal

    Approaches 1 when there is an absence of diastolic flow

    IRVF

    Look for vein in parenchyma

     

    from JACC HF 2016;4(8):683

     
    Katie Wiskar Tutorial


    Katie's Slide of Confounding Factors
    Venous Excess Chapter from Phillipe's Book
    venous-congestion-chapter
    More from Phillipe on this Topic

    * EMCrit Podcast 240- Renal Compartment Syndrome It's all about the Venous Side and We've Been Fracking it up for Years
    * Posts on Thinking CC
    * Vexus Lite
    * VEXUS Mini-Tutorial with Live Vid of a Scan

    Literature

    * Tang Editorial JACCHF 2016
    * VEXUS 2020

    Resus Crisis Manual

    Now on to the Podcast...
    25 min
  • EMCrit 262 – Midlines – Part 1
    Today on the podcast, we discuss Midlines. This is the first of two parts. In a week, I will interview Rory Spiegel on the topic, so send me your thoughts and questions in anticipation of that episode.
    Our Article

    * Utility of Midlines in Ann Emerg Med 2020

    What the Heck is a Midline?
    a 8-25 cm catheter that is placed in the arm and doesn't extend past the shoulder
    Why Ultrasound-Guided IVs Suck?

    * They aren't long enough [30021833]
    * Nearly 1/2 of them are dislodged in 24 hrs [Ann Emerg Med 1999;34(6):711]
    * Another study demonstrating they do not last [AJEM 2010;28:1]
    * Vessel Depth and Catheter Depth are the key to longevity [AJEM 2011 Fields et al.]
    * Need 2.75 cm in the vessel for good reliability [https://doi.org/10.1016/j.annemergmed.2019.11.013]
    * Midlines are better for avoidance of infections

    Which Midlines Do We Use?
    10 cm Midline
    Bard Powerglide ST


    20 cm Midline
    Medcomp 20 cm 5F CT Midline



     

     

    I take no money from any of these folks
    Video of the Dual-Lumen Midline Placement
    Start at 7:10
    Other Lit
    Safety of Midlines for
    Send Me ?s below or on Twitter
    Now on to the Podcast...
    25 min
  • EMCrit 261 – Thrombolysis during Cardiac Arrest

    [featimage]
    Do you administer thrombolytics during cardiac arrest? Or maybe you don't believe in thrombolytics, but are totally down with fibrinolytics during arrest. Who do you administer them to and which one do you use? I give you my own circuitous ramblings on the topic in this episode.
    Who Should Get Lysed?



    SR/MA

    * Wang et al.

    RCT Mentioned

    * TROICA (19092151)

    Studies not Included in that SR/MA




    * PEAPETT (27422214) (RebelM Review)
    * French Registry Trial (31381884)






    What Lytic?



    Full Dose Tenecteplase via Manufacturer Recs or 50 mg of Alteplase by IV Push over ~60 seconds (29880524)





    How Long Should You Keep Going?








    * 30-60 minutes after lytic administration

    ===Ad from Friends===
    EZDrips APP
    “EZDrips is a non-profit application that facilitates the administration of medications in adult and pediatric resuscitation and critical care. You enter the patient’s weight and the app does the rest for you. We are not on the App Store so visit us at www.ezdrips.com. The first 200 subscribers at www.ezdrips.com/emcrit get the app for free, for life!”
    Thanks again!Fred and JF

    Update
    Evidence on the lack of utility of the RV during arrest to dx PE
    Now on to the Podcast...


    22 min
  • EMCrit 260 – Thoughts on the NEJM Acute Upper Airway Obstruction Review
    [featimage]

    NEJM recently published an interesting review article on upper airway obstruction. This podcast was spurred by a rantorial on twitter by Farkas regarding the article:

    https://twitter.com/PulmCrit/status/1195103809745440768?s=20

    I took a look--and it was indeed bad...
    Here is the Article:
    Eskander et al. Acute Upper Airway Obstruction
    Some Additional References
    Here is the review article on which some of the flawed messages of the NEJM piece are based:

    * Cricothyrotomy versus Trachetomy: An Otolaryngologist's Perspective. Laryngoscope. 1988 Feb;98(2):131-5.

    These two pieces from the ENT and OMFS literature correct these errors:

    * Cricothyrotomy: When, Why and Why Not: Am J Otolaryng 2000;21(3):195
    * Elective Surgical Cricothyroidotomy in Oral and Maxillofacial Surgery Br J Oral Max Surg 2013;51:779

    Updates:
    Best Practices for Emerg Surg Airway (Laryng Invest Otolaryng 2019;4:602)
    Now on to the Podcast...
     
    22 min
  • EMCrit 258 – Should Andexxa be added to a Hospital’s Formulary?
    The question of the use of Andexxa, a reversal agent for Factor Xa Inhibitors, has been batting around my brain for a few months now. We are in the unfortunate position of having a drug with very questionable evidentiary support but with an FDA labelled indication. I received an email from the lead author of paper just published in Neurocritical Care.

    * Peled et al. Key Points to Consider When Evaluating Andexxa for Formulary Addition. Neurocrit Care 10.1007/s12028-019-00866-6

    Dr. Harry Peled is the medical director of Cardiology and Critical Care at St Jude Medical Center in California. Relevantly, he is also chair of the Pharmacy an Therapeutics Committee.

    I would love to hear your thoughts on this issue--place them in the comments below.
    See Also

    * I Have Issues with Andexanet by K. Kipp, PharmD

    Update:

    * In-Vivo Trial of 4-Factor PCC for Reversal of Xas

    Now on to the Podcast...
    19 min